To our knowledge, this is the first study to examine serum bilirubin concentrations in multiple forms of dementia with Aβ deposition, and more importantly, this represents the first preliminary study to examine the benefits of intravenous albumin infusion for the treatment of AD. Here, ALB is linked to Alzheimer disease.